{
  "DOI": "10.1186/s40246-021-00359-8",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-021-00359-8",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eSingle-variant associations with age-related macular degeneration (AMD), one of the most prevalent causes of irreversible vision loss worldwide, have been studied extensively. However, because of a lack of refinement of these associations, there remains considerable ambiguity regarding what constitutes genetic risk and/or protection for this disease, and how genetic combinations affect this risk. In this study, we consider the two most common and strongly AMD-associated loci, the \u003cjats:italic\u003eCFH-CFHR5\u003c/jats:italic\u003e region on chromosome 1q32  (Chr1 locus) and \u003cjats:italic\u003eARMS2/HTRA1\u003c/jats:italic\u003e gene on chromosome 10q26  (Chr10 locus).\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eBy refining associations within the \u003cjats:italic\u003eCFH-CFHR5\u003c/jats:italic\u003e locus, we show that all genetic protection against the development of AMD in this region is described by the combination of the amino acid-altering variant \u003cjats:italic\u003eCFH\u003c/jats:italic\u003e I62V (rs800292) and genetic deletion of \u003cjats:italic\u003eCFHR3/1\u003c/jats:italic\u003e. Haplotypes based on \u003cjats:italic\u003eCFH\u003c/jats:italic\u003e I62V, a \u003cjats:italic\u003eCFHR3/1\u003c/jats:italic\u003e deletion tagging SNP and the risk variant \u003cjats:italic\u003eCFH\u003c/jats:italic\u003e Y402H are associated with either risk, protection or neutrality for AMD and capture more than 99% of control- and case-associated chromosomes. We find that genetic combinations of \u003cjats:italic\u003eCFH-CFHR5\u003c/jats:italic\u003e haplotypes (diplotypes) strongly influence AMD susceptibility and that individuals with risk/protective diplotypes are substantially protected against the development of disease. Finally, we demonstrate that AMD risk in the \u003cjats:italic\u003eARMS2/HTRA1\u003c/jats:italic\u003e locus is also mitigated by combinations of \u003cjats:italic\u003eCFH-CFHR5\u003c/jats:italic\u003e haplotypes, with Chr10 risk variants essentially neutralized by protective \u003cjats:italic\u003eCFH\u003c/jats:italic\u003e-\u003cjats:italic\u003eCFHR5\u003c/jats:italic\u003e haplotypes.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n                \u003cjats:p\u003eOur study highlights the importance of considering protective \u003cjats:italic\u003eCFH-CFHR5\u003c/jats:italic\u003e haplotypes when assessing genetic susceptibility for AMD. It establishes a framework that describes the full spectrum of AMD susceptibility using an optimal set of single-nucleotide polymorphisms with known functional consequences. It also indicates that protective or preventive complement-directed therapies targeting AMD driven by \u003cjats:italic\u003eCFH-CFHR5\u003c/jats:italic\u003e risk haplotypes may also be effective when AMD is driven by \u003cjats:italic\u003eARMS2/HTRA1\u003c/jats:italic\u003e risk variants.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "359"
  ],
  "article-number": "60",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "27 May 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "7 September 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "25 September 2021"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The study adhered to the tenets of the Declaration of Helsinki and was approved by the Institutional Review Boards of the University of Utah and University of Iowa, where all research was performed. All participants provided informed written research consent at the time of recruitment."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "All participants provided informed written research consent at the time of recruitment, which covered publication of said research."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "GSH is a shareholder, consultant and co-founder of Voyant Biotherapeutics, LLC. GSH, CP, BLW and BTR are inventors on patents and patent applications owned by the University of Utah. JLH is the spouse of GSH. None of the other authors have any relevant proprietary interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Pappas",
      "given": "Chris M.",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-3689-7748",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Zouache",
      "given": "Moussa A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Matthews",
      "given": "Stacie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Faust",
      "given": "Caitlin D.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hageman",
      "given": "Jill L.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Williams",
      "given": "Brandi L.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Richards",
      "given": "Burt T.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hageman",
      "given": "Gregory S.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        9,
        25
      ]
    ],
    "date-time": "2021-09-25T20:02:32Z",
    "timestamp": 1632600152000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        9,
        25
      ]
    ],
    "date-time": "2021-09-25T20:08:29Z",
    "timestamp": 1632600509000
  },
  "funder": [
    {
      "DOI": "10.13039/100000053",
      "award": [
        "R24EY017404"
      ],
      "doi-asserted-by": "publisher",
      "name": "National Eye Institute"
    },
    {
      "DOI": "10.13039/100001818",
      "award": [
        "Unrestricted Grant"
      ],
      "doi-asserted-by": "publisher",
      "name": "Research to Prevent Blindness"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        7
      ]
    ],
    "date-time": "2024-04-07T17:15:40Z",
    "timestamp": 1712510140312
  },
  "is-referenced-by-count": 17,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2021,
        9,
        25
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2021,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            9,
            25
          ]
        ],
        "date-time": "2021-09-25T00:00:00Z",
        "timestamp": 1632528000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            9,
            25
          ]
        ],
        "date-time": "2021-09-25T00:00:00Z",
        "timestamp": 1632528000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-021-00359-8.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-021-00359-8/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-021-00359-8.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2021,
        9,
        25
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        9,
        25
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1001/archopht.122.4.564",
      "author": "DS Friedman",
      "doi-asserted-by": "publisher",
      "first-page": "564",
      "journal-title": "Arch Ophthalmol",
      "key": "359_CR1",
      "unstructured": "Friedman DS, O’Colmain BJ, Muñoz B, Tomany SC, McCarty C, de Jong PTVM, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–72. https://doi.org/10.1001/archopht.122.4.564.",
      "volume": "122",
      "year": "2004"
    },
    {
      "DOI": "10.1167/iovs.13-12789",
      "author": "R Klein",
      "doi-asserted-by": "publisher",
      "first-page": "ORSF5",
      "journal-title": "Investig Ophthalmol Vis Sci",
      "key": "359_CR2",
      "unstructured": "Klein R, Klein BEK. The prevalence of age-related eye diseases and visual impairment in aging: current estimates. Investig Ophthalmol Vis Sci. 2013;54:ORSF5–13. https://doi.org/10.1167/iovs.13-12789.",
      "volume": "54",
      "year": "2013"
    },
    {
      "DOI": "10.1016/S2214-109X(13)70145-1",
      "author": "WL Wong",
      "doi-asserted-by": "publisher",
      "first-page": "e106",
      "journal-title": "Lancet Glob Health",
      "key": "359_CR3",
      "unstructured": "Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106–16. https://doi.org/10.1016/S2214-109X(13)70145-1.",
      "volume": "2",
      "year": "2014"
    },
    {
      "DOI": "10.1111/j.1755-3768.1990.tb01898.x",
      "author": "T Vinding",
      "doi-asserted-by": "publisher",
      "first-page": "162",
      "journal-title": "Acta Ophthalmol (Copenh)",
      "key": "359_CR4",
      "unstructured": "Vinding T. Visual impairment of age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol (Copenh). 1990;68:162–7.",
      "volume": "68",
      "year": "1990"
    },
    {
      "author": "R Klein",
      "first-page": "182",
      "journal-title": "Investig Ophthalmol Vis Sci",
      "key": "359_CR5",
      "unstructured": "Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Investig Ophthalmol Vis Sci. 1995;36:182–91.",
      "volume": "36",
      "year": "1995"
    },
    {
      "DOI": "10.1007/BF01204616",
      "author": "E Midena",
      "doi-asserted-by": "publisher",
      "first-page": "179",
      "journal-title": "Doc Ophthalmol",
      "key": "359_CR6",
      "unstructured": "Midena E, Segato T, Blarzino MC, Degli AC. Macular drusen and the sensitivity of the central visual field. Doc Ophthalmol. 1994;88:179–85. https://doi.org/10.1007/BF01204616.",
      "volume": "88",
      "year": "1994"
    },
    {
      "DOI": "10.1159/000310612",
      "author": "N Stangos",
      "doi-asserted-by": "publisher",
      "first-page": "194",
      "journal-title": "Ophthalmologica",
      "key": "359_CR7",
      "unstructured": "Stangos N, Voutas S, Topouzis F, Karampatakis V. Contrast sensitivity evaluation in eyes predisposed to age-related macular degeneration and presenting normal visual acuity. Ophthalmologica. 1995;209:194–8. https://doi.org/10.1159/000310612.",
      "volume": "209",
      "year": "1995"
    },
    {
      "DOI": "10.1016/S0161-6420(89)32883-1",
      "author": "JS Sunness",
      "doi-asserted-by": "publisher",
      "first-page": "375",
      "journal-title": "Ophthalmology",
      "key": "359_CR8",
      "unstructured": "Sunness JS, Massof RW, Johnson MA, Bressler NM, Bressler SB, Fine SL. Diminished foveal sensitivity may predict the development of advanced age-related macular degeneration. Ophthalmology. 1989;96:375–81.",
      "volume": "96",
      "year": "1989"
    },
    {
      "DOI": "10.1001/archopht.1988.01060130061028",
      "author": "RC Kleiner",
      "doi-asserted-by": "publisher",
      "first-page": "55",
      "journal-title": "Arch Ophthalmol",
      "key": "359_CR9",
      "unstructured": "Kleiner RC, Enger C, Alexander MF, Fine SL. Contrast sensitivity in age-related macular degeneration. Arch Ophthalmol. 1988;106:55–7. https://doi.org/10.1001/archopht.1988.01060130061028.",
      "volume": "106",
      "year": "1988"
    },
    {
      "DOI": "10.1016/S0161-6420(01)00580-2",
      "author": "C Owsley",
      "doi-asserted-by": "publisher",
      "first-page": "1196",
      "journal-title": "Ophthalmology",
      "key": "359_CR10",
      "unstructured": "Owsley C, Jackson GR, White M, Feist R, Edwards D. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology. 2001;108:1196–202. https://doi.org/10.1016/S0161-6420(01)00580-2.",
      "volume": "108",
      "year": "2001"
    },
    {
      "DOI": "10.1167/iovs.05-1292",
      "author": "C Owsley",
      "doi-asserted-by": "publisher",
      "first-page": "1310",
      "journal-title": "Investig Ophthalmol Vis Sci",
      "key": "359_CR11",
      "unstructured": "Owsley C, McGwin G, Jackson GR, Heimburger DC, Piyathilake CJ, Klein R, et al. Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy. Investig Ophthalmol Vis Sci. 2006;47:1310–8. https://doi.org/10.1167/iovs.05-1292.",
      "volume": "47",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.ophtha.2015.09.041",
      "author": "C Owsley",
      "doi-asserted-by": "publisher",
      "first-page": "344",
      "journal-title": "Ophthalmology",
      "key": "359_CR12",
      "unstructured": "Owsley C, McGwin G, Clark ME, Jackson GR, Callahan MA, Kline LB, et al. Delayed rod-mediated dark adaptation is a functional biomarker for incident early age-related macular degeneration. Ophthalmology. 2016;123:344–51. https://doi.org/10.1016/j.ophtha.2015.09.041.",
      "volume": "123",
      "year": "2016"
    },
    {
      "author": "CA Curcio",
      "first-page": "1236",
      "journal-title": "Investig Ophthalmol Vis Sci",
      "key": "359_CR13",
      "unstructured": "Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in age-related macular degeneration. Investig Ophthalmol Vis Sci. 1996;37:1236–49.",
      "volume": "37",
      "year": "1996"
    },
    {
      "DOI": "10.1038/eye.2001.140",
      "author": "CA Curcio",
      "doi-asserted-by": "publisher",
      "first-page": "376",
      "issue": "Pt 3",
      "journal-title": "Eye (London)",
      "key": "359_CR14",
      "unstructured": "Curcio CA. Photoreceptor topography in ageing and age-related maculopathy. Eye (London). 2001;15(Pt 3):376–83. https://doi.org/10.1038/eye.2001.140.",
      "volume": "15",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S0039-6257(05)80092-X",
      "author": "AC Bird",
      "doi-asserted-by": "publisher",
      "first-page": "367",
      "journal-title": "Surv Ophthalmol",
      "key": "359_CR15",
      "unstructured": "Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol. 1995;39:367–74. https://doi.org/10.1016/S0039-6257(05)80092-X.",
      "volume": "39",
      "year": "1995"
    },
    {
      "DOI": "10.1016/j.ophtha.2012.03.053",
      "author": "DF Martin",
      "doi-asserted-by": "publisher",
      "first-page": "1388",
      "journal-title": "Ophthalmology",
      "key": "359_CR16",
      "unstructured": "Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, Fine SL, Ying G, Jaffe GJ, et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. 2012;119:1388–98. https://doi.org/10.1016/j.ophtha.2012.03.053.",
      "volume": "119",
      "year": "2012"
    },
    {
      "DOI": "10.1167/iovs.10-6080",
      "author": "B Kloeckener-Gruissem",
      "doi-asserted-by": "publisher",
      "first-page": "4694",
      "journal-title": "Investig Ophthalmol Vis Sci",
      "key": "359_CR17",
      "unstructured": "Kloeckener-Gruissem B, Barthelmes D, Labs S, Schindler C, Kurz-Levin M, Michels S, et al. Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD. Investig Ophthalmol Vis Sci. 2011;52:4694–702. https://doi.org/10.1167/iovs.10-6080.",
      "volume": "52",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.ophtha.2008.10.018",
      "author": "DM Brown",
      "doi-asserted-by": "publisher",
      "first-page": "57",
      "journal-title": "Ophthalmology",
      "key": "359_CR18",
      "unstructured": "Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology. 2009;116:57-65.e5. https://doi.org/10.1016/j.ophtha.2008.10.018.",
      "volume": "116",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s10384-010-0866-1",
      "author": "YJ Byun",
      "doi-asserted-by": "publisher",
      "first-page": "571",
      "journal-title": "Jpn J Ophthalmol",
      "key": "359_CR19",
      "unstructured": "Byun YJ, Lee SJ, Koh HJ. Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Jpn J Ophthalmol. 2010;54:571–7. https://doi.org/10.1007/s10384-010-0866-1.",
      "volume": "54",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.ophtha.2010.07.011",
      "author": "PJ Rosenfeld",
      "doi-asserted-by": "publisher",
      "first-page": "523",
      "journal-title": "Ophthalmology",
      "key": "359_CR20",
      "unstructured": "Rosenfeld PJ, Shapiro H, Tuomi L, Webster M, Elledge J, Blodi B, et al. Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. Ophthalmology. 2011;118:523–30. https://doi.org/10.1016/j.ophtha.2010.07.011.",
      "volume": "118",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.ophtha.2016.03.045",
      "author": "MG Maguire",
      "doi-asserted-by": "publisher",
      "first-page": "1751",
      "journal-title": "Ophthalmology",
      "key": "359_CR21",
      "unstructured": "Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Maguire MG, Martin DF, Ying G-S, Jaffe GJ, Daniel E, et al. Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2016;123:1751–61. https://doi.org/10.1016/j.ophtha.2016.03.045.",
      "volume": "123",
      "year": "2016"
    },
    {
      "DOI": "10.1073/pnas.0501536102",
      "author": "GS Hageman",
      "doi-asserted-by": "publisher",
      "first-page": "7227",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "359_CR22",
      "unstructured": "Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA. 2005;102:7227–32. https://doi.org/10.1073/pnas.0501536102.",
      "volume": "102",
      "year": "2005"
    },
    {
      "DOI": "10.1126/science.1109557",
      "author": "RJ Klein",
      "doi-asserted-by": "publisher",
      "first-page": "385",
      "journal-title": "Science",
      "key": "359_CR23",
      "unstructured": "Klein RJ, Zeiss C, Chew EY, Tsai J-Y, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385–9. https://doi.org/10.1126/science.1109557.",
      "volume": "308",
      "year": "2005"
    },
    {
      "DOI": "10.1126/science.1110189",
      "author": "AO Edwards",
      "doi-asserted-by": "publisher",
      "first-page": "421",
      "journal-title": "Science",
      "key": "359_CR24",
      "unstructured": "Edwards AO, Ritter R, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421–4. https://doi.org/10.1126/science.1110189.",
      "volume": "308",
      "year": "2005"
    },
    {
      "DOI": "10.1038/ng1890",
      "author": "AE Hughes",
      "doi-asserted-by": "publisher",
      "first-page": "1173",
      "journal-title": "Nat Genet",
      "key": "359_CR25",
      "unstructured": "Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet. 2006;38:1173–7. https://doi.org/10.1038/ng1890.",
      "volume": "38",
      "year": "2006"
    },
    {
      "DOI": "10.1086/431426",
      "author": "S Zareparsi",
      "doi-asserted-by": "publisher",
      "first-page": "149",
      "journal-title": "Am J Hum Genet",
      "key": "359_CR26",
      "unstructured": "Zareparsi S, Branham KEH, Li M, Shah S, Klein RJ, Ott J, et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet. 2005;77:149–53. https://doi.org/10.1086/431426.",
      "volume": "77",
      "year": "2005"
    },
    {
      "DOI": "10.1038/ng1871",
      "author": "M Li",
      "doi-asserted-by": "publisher",
      "first-page": "1049",
      "journal-title": "Nat Genet",
      "key": "359_CR27",
      "unstructured": "Li M, Atmaca-Sonmez P, Othman M, Branham KEH, Khanna R, Wade MS, et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet. 2006;38:1049–54. https://doi.org/10.1038/ng1871.",
      "volume": "38",
      "year": "2006"
    },
    {
      "DOI": "10.1093/hmg/ddi353",
      "author": "A Rivera",
      "doi-asserted-by": "publisher",
      "first-page": "3227",
      "journal-title": "Hum Mol Genet",
      "key": "359_CR28",
      "unstructured": "Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger T, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet. 2005;14:3227–36. https://doi.org/10.1093/hmg/ddi353.",
      "volume": "14",
      "year": "2005"
    },
    {
      "DOI": "10.1086/444437",
      "author": "J Jakobsdottir",
      "doi-asserted-by": "publisher",
      "first-page": "389",
      "journal-title": "Am J Hum Genet",
      "key": "359_CR29",
      "unstructured": "Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet. 2005;77:389–407. https://doi.org/10.1086/444437.",
      "volume": "77",
      "year": "2005"
    },
    {
      "DOI": "10.1038/ng1873",
      "author": "J Maller",
      "doi-asserted-by": "publisher",
      "first-page": "1055",
      "journal-title": "Nat Genet",
      "key": "359_CR30",
      "unstructured": "Maller J, George S, Purcell S, Fagerness J, Altshuler D, Daly MJ, et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet. 2006;38:1055–9. https://doi.org/10.1038/ng1873.",
      "volume": "38",
      "year": "2006"
    },
    {
      "DOI": "10.1038/ng2131",
      "author": "JB Maller",
      "doi-asserted-by": "publisher",
      "first-page": "1200",
      "journal-title": "Nat Genet",
      "key": "359_CR31",
      "unstructured": "Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet. 2007;39:1200–1. https://doi.org/10.1038/ng2131.",
      "volume": "39",
      "year": "2007"
    },
    {
      "DOI": "10.1038/ejhg.2008.140",
      "author": "JA Fagerness",
      "doi-asserted-by": "publisher",
      "first-page": "100",
      "journal-title": "Eur J Hum Genet",
      "key": "359_CR32",
      "unstructured": "Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM. Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet. 2009;17:100–4. https://doi.org/10.1038/ejhg.2008.140.",
      "volume": "17",
      "year": "2009"
    },
    {
      "DOI": "10.1371/journal.pone.0037979",
      "author": "F Grassmann",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS ONE",
      "key": "359_CR33",
      "unstructured": "Grassmann F, Fritsche LG, Keilhauer CN, Heid IM, Weber BHF. Modelling the genetic risk in age-related macular degeneration. PLoS ONE. 2012;7: e37979. https://doi.org/10.1371/journal.pone.0037979.",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.1038/ng.3448",
      "author": "LG Fritsche",
      "doi-asserted-by": "publisher",
      "first-page": "134",
      "journal-title": "Nat Genet",
      "key": "359_CR34",
      "unstructured": "Fritsche LG, Igl W, Bailey JNC, Grassmann F, Sengupta S, Bragg-Gresham JL, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48:134–43. https://doi.org/10.1038/ng.3448.",
      "volume": "48",
      "year": "2016"
    },
    {
      "DOI": "10.1146/annurev-genom-090413-025610",
      "author": "LG Fritsche",
      "doi-asserted-by": "publisher",
      "first-page": "151",
      "journal-title": "Annu Rev Genom Hum Genet",
      "key": "359_CR35",
      "unstructured": "Fritsche LG, Fariss RN, Stambolian D, Abecasis GR, Curcio CA, Swaroop A. Age-related macular degeneration: genetics and biology coming together. Annu Rev Genom Hum Genet. 2014;15:151–71. https://doi.org/10.1146/annurev-genom-090413-025610.",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1038/ng.2578",
      "author": "LG Fritsche",
      "doi-asserted-by": "publisher",
      "first-page": "433",
      "journal-title": "Nat Genet",
      "key": "359_CR36",
      "unstructured": "Fritsche LG, Chen W, Schu M, Yaspan BL, Yu Y, Thorleifsson G, et al. Seven new loci associated with age-related macular degeneration. Nat Genet. 2013;45:433–9. https://doi.org/10.1038/ng.2578.",
      "volume": "45",
      "year": "2013"
    },
    {
      "DOI": "10.1534/genetics.116.195966",
      "author": "F Grassmann",
      "doi-asserted-by": "publisher",
      "first-page": "919",
      "journal-title": "Genetics",
      "key": "359_CR37",
      "unstructured": "Grassmann F, Heid IM, Weber BHF, International AMD Genomics Consortium (IAMDGC). Recombinant haplotypes narrow the ARMS2/HTRA1 association signal for age-related macular degeneration. Genetics. 2017;205:919–24. https://doi.org/10.1534/genetics.116.195966.",
      "volume": "205",
      "year": "2017"
    },
    {
      "DOI": "10.1080/07853890601097030",
      "author": "GS Hageman",
      "doi-asserted-by": "publisher",
      "first-page": "592",
      "journal-title": "Ann Med",
      "key": "359_CR38",
      "unstructured": "Hageman GS, Hancox LS, Taiber AJ, Gehrs KM, Anderson DH, Johnson LV, et al. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med. 2006;38:592–604.",
      "volume": "38",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nrg4017",
      "author": "AR Harper",
      "doi-asserted-by": "publisher",
      "first-page": "689",
      "journal-title": "Nat Rev Genet",
      "key": "359_CR39",
      "unstructured": "Harper AR, Nayee S, Topol EJ. Protective alleles and modifier variants in human health and disease. Nat Rev Genet. 2015;16:689–701. https://doi.org/10.1038/nrg4017.",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ng0710-553",
      "author": "S Raychaudhuri",
      "doi-asserted-by": "publisher",
      "first-page": "553",
      "journal-title": "Nat Genet",
      "key": "359_CR40",
      "unstructured": "Raychaudhuri S, Ripke S, Li M, Neale BM, Fagerness J, Reynolds R, et al. Associations of CFHR1-CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent. Nat Genet. 2010;42:553–5. https://doi.org/10.1038/ng0710-553 (author reply 555).",
      "volume": "42",
      "year": "2010"
    },
    {
      "DOI": "10.1038/s41467-020-14499-3",
      "author": "V Cipriani",
      "doi-asserted-by": "publisher",
      "first-page": "778",
      "journal-title": "Nat Commun",
      "key": "359_CR41",
      "unstructured": "Cipriani V, Lorés-Motta L, He F, Fathalla D, Tilakaratna V, McHarg S, et al. Increased circulating levels of factor H-related protein 4 are strongly associated with age-related macular degeneration. Nat Commun. 2020;11:778. https://doi.org/10.1038/s41467-020-14499-3.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1093/hmg/ddq399",
      "author": "LG Fritsche",
      "doi-asserted-by": "publisher",
      "first-page": "4694",
      "journal-title": "Hum Mol Genet",
      "key": "359_CR42",
      "unstructured": "Fritsche LG, Lauer N, Hartmann A, Stippa S, Keilhauer CN, Oppermann M, et al. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Hum Mol Genet. 2010;19:4694–704. https://doi.org/10.1093/hmg/ddq399.",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1167/iovs.09-3975",
      "author": "KE Schmid-Kubista",
      "doi-asserted-by": "publisher",
      "first-page": "5070",
      "journal-title": "Investig Ophthalmol Vis Sci",
      "key": "359_CR43",
      "unstructured": "Schmid-Kubista KE, Tosakulwong N, Wu Y, Ryu E, Hecker LA, Baratz KH, et al. Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration. Investig Ophthalmol Vis Sci. 2009;50:5070–9. https://doi.org/10.1167/iovs.09-3975.",
      "volume": "50",
      "year": "2009"
    },
    {
      "DOI": "10.1093/hmg/ddm369",
      "author": "KL Spencer",
      "doi-asserted-by": "publisher",
      "first-page": "971",
      "journal-title": "Hum Mol Genet",
      "key": "359_CR44",
      "unstructured": "Spencer KL, Hauser MA, Olson LM, Schmidt S, Scott WK, Gallins P, et al. Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration. Hum Mol Genet. 2008;17:971–7. https://doi.org/10.1093/hmg/ddm369.",
      "volume": "17",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.molimm.2018.06.011",
      "author": "EG de Jorge",
      "doi-asserted-by": "publisher",
      "first-page": "42",
      "journal-title": "Mol Immunol",
      "key": "359_CR45",
      "unstructured": "de Jorge EG, Lera AL, Bayarri-Olmos R, Yebenes H, Lopez-Trascasa M, de Córdoba SR. Common and rare genetic variants of complement components in human disease. Mol Immunol. 2018;102:42–57. https://doi.org/10.1016/j.molimm.2018.06.011.",
      "volume": "102",
      "year": "2018"
    },
    {
      "DOI": "10.1167/iovs.11-8709",
      "author": "R Martínez-Barricarte",
      "doi-asserted-by": "publisher",
      "first-page": "1087",
      "journal-title": "Investig Ophthalmol Vis Sci",
      "key": "359_CR46",
      "unstructured": "Martínez-Barricarte R, Recalde S, Fernández-Robredo P, Millán I, Olavarrieta L, Viñuela A, et al. Relevance of complement factor H-related 1 (CFHR1) genotypes in age-related macular degeneration. Investig Ophthalmol Vis Sci. 2012;53:1087–94. https://doi.org/10.1167/iovs.11-8709.",
      "volume": "53",
      "year": "2012"
    },
    {
      "DOI": "10.1167/iovs.06-1427",
      "author": "KL Spencer",
      "doi-asserted-by": "publisher",
      "first-page": "4277",
      "journal-title": "Investig Ophthalmol Vis Sci",
      "key": "359_CR47",
      "unstructured": "Spencer KL, Hauser MA, Olson LM, Schnetz-Boutaud N, Scott WK, Schmidt S, et al. Haplotypes spanning the complement factor H gene are protective against age-related macular degeneration. Investig Ophthalmol Vis Sci. 2007;48:4277–83. https://doi.org/10.1167/iovs.06-1427.",
      "volume": "48",
      "year": "2007"
    },
    {
      "DOI": "10.1084/jem.20070301",
      "author": "MC Pickering",
      "doi-asserted-by": "publisher",
      "first-page": "1249",
      "journal-title": "J Exp Med",
      "key": "359_CR48",
      "unstructured": "Pickering MC, de Jorge EG, Martinez-Barricarte R, Recalde S, Garcia-Layana A, Rose KL, et al. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J Exp Med. 2007;204:1249–56. https://doi.org/10.1084/jem.20070301.",
      "volume": "204",
      "year": "2007"
    },
    {
      "DOI": "10.1111/j.1365-2249.2007.03552.x",
      "author": "SR de Córdoba",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Clin Exp Immunol",
      "key": "359_CR49",
      "unstructured": "de Córdoba SR, de Jorge EG. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin Exp Immunol. 2008;151:1–13. https://doi.org/10.1111/j.1365-2249.2007.03552.x.",
      "volume": "151",
      "year": "2008"
    },
    {
      "DOI": "10.1038/ng0710-555",
      "author": "AE Hughes",
      "doi-asserted-by": "publisher",
      "first-page": "555",
      "journal-title": "Nat Genet",
      "key": "359_CR50",
      "unstructured": "Hughes AE, Orr N, Cordell HJ, Goodship T. Reply to “Associations of CFHR1–CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent.” Nat Genet. 2010;42:555–6. https://doi.org/10.1038/ng0710-555.",
      "volume": "42",
      "year": "2010"
    },
    {
      "DOI": "10.1038/s41598-020-78059-x",
      "author": "MA Zouache",
      "doi-asserted-by": "publisher",
      "first-page": "21093",
      "journal-title": "Sci Rep",
      "key": "359_CR51",
      "unstructured": "Zouache MA, Bennion A, Hageman JL, Pappas C, Richards BT, Hageman GS. Macular retinal thickness differs markedly in age-related macular degeneration driven by risk polymorphisms on chromosomes 1 and 10. Sci Rep. 2020;10:21093. https://doi.org/10.1038/s41598-020-78059-x.",
      "volume": "10",
      "year": "2020"
    },
    {
      "DOI": "10.1167/iovs.15-17009",
      "author": "TDL Keenan",
      "doi-asserted-by": "publisher",
      "first-page": "4870",
      "journal-title": "Investig Ophthalmol Vis Sci",
      "key": "359_CR52",
      "unstructured": "Keenan TDL, Toso M, Pappas C, Nichols L, Bishop PN, Hageman GS. Assessment of proteins associated with complement activation and inflammation in maculae of human donors homozygous risk at chromosome 1 CFH-to-F13B. Investig Ophthalmol Vis Sci. 2015;56:4870–9. https://doi.org/10.1167/iovs.15-17009.",
      "volume": "56",
      "year": "2015"
    },
    {
      "DOI": "10.1093/hmg/ddp289",
      "author": "A Tortajada",
      "doi-asserted-by": "publisher",
      "first-page": "3452",
      "journal-title": "Hum Mol Genet",
      "key": "359_CR53",
      "unstructured": "Tortajada A, Montes T, Martínez-Barricarte R, Morgan BP, Harris CL, de Córdoba SR. The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity. Hum Mol Genet. 2009;18:3452–61. https://doi.org/10.1093/hmg/ddp289.",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1093/hmg/ddt336",
      "author": "M Ansari",
      "doi-asserted-by": "publisher",
      "first-page": "4857",
      "journal-title": "Hum Mol Genet",
      "key": "359_CR54",
      "unstructured": "Ansari M, McKeigue PM, Skerka C, Hayward C, Rudan I, Vitart V, et al. Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration. Hum Mol Genet. 2013;22:4857–69. https://doi.org/10.1093/hmg/ddt336.",
      "volume": "22",
      "year": "2013"
    },
    {
      "author": "PJ Francis",
      "first-page": "1395",
      "journal-title": "Mol Vis",
      "key": "359_CR55",
      "unstructured": "Francis PJ, Zhang H, Dewan A, Hoh J, Klein ML. Joint effects of polymorphisms in the HTRA1, LOC387715/ARMS2, and CFH genes on AMD in a Caucasian population. Mol Vis. 2008;14:1395–400.",
      "volume": "14",
      "year": "2008"
    },
    {
      "DOI": "10.1126/science.1133811",
      "author": "Z Yang",
      "doi-asserted-by": "publisher",
      "first-page": "992",
      "journal-title": "Science",
      "key": "359_CR56",
      "unstructured": "Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science. 2006;314:992–3. https://doi.org/10.1126/science.1133811.",
      "volume": "314",
      "year": "2006"
    },
    {
      "DOI": "10.1093/biomet/80.1.27",
      "author": "D Firth",
      "doi-asserted-by": "publisher",
      "first-page": "27",
      "journal-title": "Biometrika",
      "key": "359_CR57",
      "unstructured": "Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80:27–38. https://doi.org/10.1093/biomet/80.1.27.",
      "volume": "80",
      "year": "1993"
    },
    {
      "DOI": "10.1074/jbc.M110.103986",
      "author": "SJ Clark",
      "doi-asserted-by": "publisher",
      "first-page": "30192",
      "journal-title": "J Biol Chem",
      "key": "359_CR58",
      "unstructured": "Clark SJ, Perveen R, Hakobyan S, Morgan BP, Sim RB, Bishop PN, et al. Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch’s membrane in human retina. J Biol Chem. 2010;285:30192–202. https://doi.org/10.1074/jbc.M110.103986.",
      "volume": "285",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.molimm.2007.02.012",
      "author": "C Skerka",
      "doi-asserted-by": "publisher",
      "first-page": "3398",
      "journal-title": "Mol Immunol",
      "key": "359_CR59",
      "unstructured": "Skerka C, Lauer N, Weinberger AAWA, Keilhauer CN, Sühnel J, Smith R, et al. Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. Mol Immunol. 2007;44:3398–406. https://doi.org/10.1016/j.molimm.2007.02.012.",
      "volume": "44",
      "year": "2007"
    },
    {
      "DOI": "10.4049/jimmunol.178.6.3831",
      "author": "M Laine",
      "doi-asserted-by": "publisher",
      "first-page": "3831",
      "journal-title": "J Immunol",
      "key": "359_CR60",
      "unstructured": "Laine M, Jarva H, Seitsonen S, Haapasalo K, Lehtinen MJ, Lindeman N, et al. Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J Immunol. 2007;178:3831–6. https://doi.org/10.4049/jimmunol.178.6.3831.",
      "volume": "178",
      "year": "2007"
    },
    {
      "DOI": "10.1073/pnas.0606234103",
      "author": "PT Johnson",
      "doi-asserted-by": "publisher",
      "first-page": "17456",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "359_CR61",
      "unstructured": "Johnson PT, Betts KE, Radeke MJ, Hageman GS, Anderson DH, Johnson LV. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci USA. 2006;103:17456–61. https://doi.org/10.1073/pnas.0606234103.",
      "volume": "103",
      "year": "2006"
    },
    {
      "DOI": "10.1074/jbc.M605083200",
      "author": "SJ Clark",
      "doi-asserted-by": "publisher",
      "first-page": "24713",
      "journal-title": "J Biol Chem",
      "key": "359_CR62",
      "unstructured": "Clark SJ, Higman VA, Mulloy B, Perkins SJ, Lea SM, Sim RB, et al. His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. J Biol Chem. 2006;281:24713–20. https://doi.org/10.1074/jbc.M605083200.",
      "volume": "281",
      "year": "2006"
    },
    {
      "DOI": "10.1084/jem.20071069",
      "author": "BE Prosser",
      "doi-asserted-by": "publisher",
      "first-page": "2277",
      "journal-title": "J Exp Med",
      "key": "359_CR63",
      "unstructured": "Prosser BE, Johnson S, Roversi P, Herbert AP, Blaum BS, Tyrrell J, et al. Structural basis for complement factor H linked age-related macular degeneration. J Exp Med. 2007;204:2277–83. https://doi.org/10.1084/jem.20071069.",
      "volume": "204",
      "year": "2007"
    },
    {
      "DOI": "10.1073/pnas.1913970117",
      "author": "L Alic",
      "doi-asserted-by": "publisher",
      "first-page": "9942",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "359_CR64",
      "unstructured": "Alic L, Papac-Milicevic N, Czamara D, Rudnick RB, Ozsvar-Kozma M, Hartmann A, et al. A genome-wide association study identifies key modulators of complement factor H binding to malondialdehyde-epitopes. Proc Natl Acad Sci USA. 2020;117:9942–51. https://doi.org/10.1073/pnas.1913970117.",
      "volume": "117",
      "year": "2020"
    },
    {
      "author": "V Cipriani",
      "first-page": "3870",
      "issue": "9",
      "journal-title": "Investig Ophthalmol Vis Sci",
      "key": "359_CR65",
      "unstructured": "Cipriani V, de Motta LL, He F, Fathalla D, McHarg S, Bayatti N, et al. Factor H-Related Protein 4 (FHR-4) drives complement dysregulation in age-related macular degeneration. Investig Ophthalmol Vis Sci. 2019;60(9):3870–3870.",
      "volume": "60",
      "year": "2019"
    },
    {
      "DOI": "10.1038/ng.170",
      "author": "LG Fritsche",
      "doi-asserted-by": "publisher",
      "first-page": "892",
      "journal-title": "Nat Genet",
      "key": "359_CR66",
      "unstructured": "Fritsche LG, Loenhardt T, Janssen A, Fisher SA, Rivera A, Keilhauer CN, et al. Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet. 2008;40:892–6. https://doi.org/10.1038/ng.170.",
      "volume": "40",
      "year": "2008"
    },
    {
      "DOI": "10.1073/pnas.0703933104",
      "author": "A Kanda",
      "doi-asserted-by": "publisher",
      "first-page": "16227",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "359_CR67",
      "unstructured": "Kanda A, Chen W, Othman M, Branham KEH, Brooks M, Khanna R, et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci USA. 2007;104:16227–32. https://doi.org/10.1073/pnas.0703933104.",
      "volume": "104",
      "year": "2007"
    },
    {
      "DOI": "10.1167/iovs.09-3850",
      "author": "E Kortvely",
      "doi-asserted-by": "publisher",
      "first-page": "79",
      "journal-title": "Investig Ophthalmol Vis Sci",
      "key": "359_CR68",
      "unstructured": "Kortvely E, Hauck SM, Duetsch G, Gloeckner CJ, Kremmer E, Alge-Priglinger CS, et al. ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations. Investig Ophthalmol Vis Sci. 2010;51:79–88. https://doi.org/10.1167/iovs.09-3850.",
      "volume": "51",
      "year": "2010"
    },
    {
      "DOI": "10.1167/iovs.08-3240",
      "author": "G Wang",
      "doi-asserted-by": "publisher",
      "first-page": "3084",
      "journal-title": "Investig Ophthalmol Vis Sci",
      "key": "359_CR69",
      "unstructured": "Wang G, Spencer KL, Court BL, Olson LM, Scott WK, Haines JL, et al. Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria. Investig Ophthalmol Vis Sci. 2009;50:3084–90. https://doi.org/10.1167/iovs.08-3240.",
      "volume": "50",
      "year": "2009"
    },
    {
      "DOI": "10.1177/002215540305101004",
      "author": "A De Luca",
      "doi-asserted-by": "publisher",
      "first-page": "1279",
      "journal-title": "J Histochem Cytochem",
      "key": "359_CR70",
      "unstructured": "De Luca A, De Falco M, Severino A, Campioni M, Santini D, Baldi F, et al. Distribution of the serine protease HtrA1 in normal human tissues. J Histochem Cytochem. 2003;51:1279–84. https://doi.org/10.1177/002215540305101004.",
      "volume": "51",
      "year": "2003"
    },
    {
      "DOI": "10.1007/s00018-012-1076-4",
      "author": "G Hansen",
      "doi-asserted-by": "publisher",
      "first-page": "761",
      "journal-title": "Cell Mol Life Sci",
      "key": "359_CR71",
      "unstructured": "Hansen G, Hilgenfeld R. Architecture and regulation of HtrA-family proteins involved in protein quality control and stress response. Cell Mol Life Sci. 2013;70:761–75. https://doi.org/10.1007/s00018-012-1076-4.",
      "volume": "70",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.abb.2017.04.004",
      "author": "D Zurawa-Janicka",
      "doi-asserted-by": "publisher",
      "first-page": "6",
      "journal-title": "Arch Biochem Biophys",
      "key": "359_CR72",
      "unstructured": "Zurawa-Janicka D, Wenta T, Jarzab M, Skorko-Glonek J, Glaza P, Gieldon A, et al. Structural insights into the activation mechanisms of human HtrA serine proteases. Arch Biochem Biophys. 2017;621:6–23. https://doi.org/10.1016/j.abb.2017.04.004.",
      "volume": "621",
      "year": "2017"
    },
    {
      "DOI": "10.1073/pnas.2103617118",
      "author": "BL Williams",
      "doi-asserted-by": "publisher",
      "first-page": "e2103617118",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "359_CR73",
      "unstructured": "Williams BL, Seager NA, Gardiner JD, Pappas CM, Cronin MC, di San Filippo CA, et al. Chromosome 10q26-driven age-related macular degeneration is associated with reduced levels of HTRA1 in human retinal pigment epithelium. Proc Natl Acad Sci USA. 2021;118:e2103617118. https://doi.org/10.1073/pnas.2103617118.",
      "volume": "118",
      "year": "2021"
    },
    {
      "DOI": "10.1001/archopht.121.4.519",
      "author": "R van Leeuwen",
      "doi-asserted-by": "publisher",
      "first-page": "519",
      "journal-title": "Arch Ophthalmol",
      "key": "359_CR74",
      "unstructured": "van Leeuwen R, Klaver CCW, Vingerling JR, Hofman A, de Jong PTVM. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol. 2003;121:519–26. https://doi.org/10.1001/archopht.121.4.519.",
      "volume": "121",
      "year": "2003"
    },
    {
      "DOI": "10.1086/519795",
      "author": "S Purcell",
      "doi-asserted-by": "publisher",
      "first-page": "559",
      "journal-title": "Am J Hum Genet",
      "key": "359_CR75",
      "unstructured": "Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75. https://doi.org/10.1086/519795.",
      "volume": "81",
      "year": "2007"
    },
    {
      "DOI": "10.2307/3001666",
      "author": "WG Cochran",
      "doi-asserted-by": "publisher",
      "first-page": "101",
      "journal-title": "Biometrics",
      "key": "359_CR76",
      "unstructured": "Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101. https://doi.org/10.2307/3001666.",
      "volume": "10",
      "year": "1954"
    },
    {
      "DOI": "10.1002/sim.1186",
      "author": "JPT Higgins",
      "doi-asserted-by": "publisher",
      "first-page": "1539",
      "journal-title": "Stat Med",
      "key": "359_CR77",
      "unstructured": "Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58. https://doi.org/10.1002/sim.1186.",
      "volume": "21",
      "year": "2002"
    },
    {
      "DOI": "10.3389/fgene.2020.00157",
      "author": "TA Myers",
      "doi-asserted-by": "publisher",
      "first-page": "157",
      "journal-title": "Front Genet",
      "key": "359_CR78",
      "unstructured": "Myers TA, Chanock SJ, Machiela MJ. Ldlinkr: an R package for rapidly calculating linkage disequilibrium statistics in diverse populations. Front Genet. 2020;11:157. https://doi.org/10.3389/fgene.2020.00157.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1038/nature15393",
      "author": "A Auton",
      "doi-asserted-by": "publisher",
      "first-page": "68",
      "journal-title": "Nature",
      "key": "359_CR79",
      "unstructured": "1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526:68–74. https://doi.org/10.1038/nature15393.",
      "volume": "526",
      "year": "2015"
    },
    {
      "key": "359_CR80",
      "unstructured": "Team RC. R: a language and environment for statistical computing."
    },
    {
      "DOI": "10.1086/338688",
      "author": "DJ Schaid",
      "doi-asserted-by": "publisher",
      "first-page": "425",
      "journal-title": "Am J Hum Genet",
      "key": "359_CR81",
      "unstructured": "Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002;70:425–34. https://doi.org/10.1086/338688.",
      "volume": "70",
      "year": "2002"
    },
    {
      "DOI": "10.1007/s11222-019-09860-6",
      "author": "I Kosmidis",
      "doi-asserted-by": "publisher",
      "first-page": "17",
      "journal-title": "Stat Comput",
      "key": "359_CR82",
      "unstructured": "Kosmidis I, Pagui ECK, Sartori N. Mean and median bias reduction in generalized linear models. Stat Comput. 2019;1:17. https://doi.org/10.1007/s11222-019-09860-6.",
      "volume": "1",
      "year": "2019"
    },
    {
      "DOI": "10.1101/2020.08.20.258491",
      "author": "L Yin",
      "doi-asserted-by": "publisher",
      "journal-title": "BioRxiv",
      "key": "359_CR83",
      "unstructured": "Yin L, Zhang H, Tang Z, Xu J, Yin D, Zhang Z, et al. rMVP: a memory-efficient, visualization-enhanced, and parallel-accelerated tool for genome-wide association study. BioRxiv. 2020. https://doi.org/10.1101/2020.08.20.258491.",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.ophtha.2017.03.042",
      "author": "S Burgess",
      "doi-asserted-by": "publisher",
      "first-page": "1165",
      "journal-title": "Ophthalmology",
      "key": "359_CR84",
      "unstructured": "Burgess S, Davey SG. Mendelian randomization implicates high-density lipoprotein cholesterol-associated mechanisms in etiology of age-related macular degeneration. Ophthalmology. 2017;124:1165–74. https://doi.org/10.1016/j.ophtha.2017.03.042.",
      "volume": "124",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s10038-020-0750-x",
      "author": "X Han",
      "doi-asserted-by": "publisher",
      "first-page": "657",
      "journal-title": "J Hum Genet",
      "key": "359_CR85",
      "unstructured": "Han X, Gharahkhani P, Mitchell P, Liew G, Hewitt AW, MacGregor S. Genome-wide meta-analysis identifies novel loci associated with age-related macular degeneration. J Hum Genet. 2020;65:657–65. https://doi.org/10.1038/s10038-020-0750-x.",
      "volume": "65",
      "year": "2020"
    }
  ],
  "reference-count": 85,
  "references-count": 85,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-021-00359-8"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Protective chromosome 1q32 haplotypes mitigate risk for age-related macular degeneration associated with the CFH-CFHR5 and ARMS2/HTRA1 loci"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "15"
}